Showing results (1-10 of 552) with videos related to
Sort By:
Pageof 56
Expert Review of Neurotherapeutics|June 4, 2010
Use of growth factors for the treatment of Parkinson's diseaseToru Yasuda, Hideki MochizukiNihon Rinsho. Japanese Journal of Clinical Medicine|July 14, 2009
[Recent advances in cell and gene therapies for Parkinson's disease]Toru Yasuda, Hideki MochizukiJournal of Neural Transmission (Vienna, Austria : 1996)|October 17, 2012
Iron accumulation in Parkinson's diseaseHideki Mochizuki, Toru YasudaApoptosis : an International Journal on Programmed Cell Death|March 12, 2010
The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's diseaseToru Yasuda, Hideki MochizukiMolecular Neurobiology|September 1, 2012
α-Synuclein and neuronal cell deathToru Yasuda, Yasuto Nakata, Hideki MochizukiNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 9, 2008
Advances in gene therapy for movement disordersHideki Mochizuki, Toru Yasuda, M Maral MouradianParkinsonism & Related Disorders|November 23, 2013
The promises of stem cells: stem cell therapy for movement disordersHideki Mochizuki, Chi-Jing Choong, Toru YasudaTranslational Neurodegeneration|August 8, 2013
Neurodegenerative changes initiated by presynaptic dysfunctionToru Yasuda, Yasuto Nakata, Chi-Jing Choong, et al.Journal of Neuroscience Methods|August 11, 2011
Adeno-associated viral vector-mediated gene transduction in mesencephalic slice cultureTomoko Nihira, Toru Yasuda, Yukihiko Hirai, et al.The Journal of Biological Chemistry|September 24, 2004
Neurotoxic effects of lipopolysaccharide on nigral dopaminergic neurons are mediated by microglial activation, interleukin-1beta, and expression of caspase-11 in miceHiroyuki Arai, Tsuyoshi Furuya, Toru Yasuda, et al.Pageof 56